Regeneron Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all Regeneron Pharmaceuticals patents 704 in total
| Status | Patent |
|---|---|
Grant | Utility: Common light chain mouse Filling date: 12 Sep 2025 Issue date: 27 Apr 2021 |
Grant | Utility: Antibodies comprising chimeric constant domains Filling date: 12 Sep 2025 Issue date: 27 Apr 2021 |
Grant | Utility: Methods of modifying genes in eukaryotic cells Filling date: 12 Sep 2025 Issue date: 27 Apr 2021 |
Grant | Utility: Assembly line with integrated electronic visual inspection Filling date: 12 Sep 2025 Issue date: 27 Apr 2021 |
Application | Utility: PRODUCTION OF FERTILE XY FEMALE ANIMALS BY SILENCING OF GENES ON THE Y CHROMOSOME Filling date: 12 Sep 2025 Issue date: 22 Apr 2021 |
Application | Utility: Humanized M-CSF Mice Filling date: 12 Sep 2025 Issue date: 22 Apr 2021 |
Application | Utility: MULTISPECIFIC ANTIGEN-BINDING MOLECULES AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 22 Apr 2021 |
Grant | Utility: Non-human animals expressing exogenous terminal deoxynucleotidyltransferase Filling date: 12 Sep 2025 Issue date: 20 Apr 2021 |
Application | Utility: STERILISATION METHOD Filling date: 12 Sep 2025 Issue date: 15 Apr 2021 |
Application | Utility: ADAM6 MICE Filling date: 12 Sep 2025 Issue date: 15 Apr 2021 |
Application | Utility: ADAM6 MICE Filling date: 12 Sep 2025 Issue date: 15 Apr 2021 |
Application | Utility: Dual-Column LC-MS System and Methods of Use Thereof Filling date: 12 Sep 2025 Issue date: 15 Apr 2021 |
Application | Utility: Stabilized Formulations Containing Anti-NGF Antibodies Filling date: 12 Sep 2025 Issue date: 15 Apr 2021 |
Application | Utility: GENETICALLY MODIFIED MOUSE WHOSE GENOME COMPRISES A HUMANIZED CD274 GENE Filling date: 12 Sep 2025 Issue date: 15 Apr 2021 |
Application | Utility: METHODS FOR CHARACTERIZING HOST-CELL PROTEINS Filling date: 12 Sep 2025 Issue date: 15 Apr 2021 |
Application | Utility: LIQUID CHROMATOGRAPHY- MASS SPECTROMETRY (LC-MS) METHODS FOR ANALYZING AMPHOLYTE LOT VARIATION Filling date: 12 Sep 2025 Issue date: 15 Apr 2021 |
Grant | Utility: Anti-SARS-CoV-2-Spike glycoprotein antibodies and antigen-binding fragments Filling date: 12 Sep 2025 Issue date: 13 Apr 2021 |
Grant | Utility: Targeted modification of rat genome Filling date: 12 Sep 2025 Issue date: 13 Apr 2021 |
Grant | Utility: Use of a VEGF antagonist to treat angiogenic eye disorders Filling date: 12 Sep 2025 Issue date: 13 Apr 2021 |
Grant | Utility: Methods of assessing antibody-drug conjugates Filling date: 12 Sep 2025 Issue date: 13 Apr 2021 |
Application | Utility: Non-Human Animals Expressing Humanized CD3 Complex Filling date: 12 Sep 2025 Issue date: 8 Apr 2021 |
Application | Utility: High Affinity Human Antibodies to Human Angiopoietin-2 Filling date: 12 Sep 2025 Issue date: 8 Apr 2021 |
Application | Utility: High-throughput method to screen cognate T cell and epitope reactivities in primary human cells Filling date: 12 Sep 2025 Issue date: 8 Apr 2021 |
Application | Utility: CRNN LOSS OF FUNCTION RODENT MODEL Filling date: 12 Sep 2025 Issue date: 8 Apr 2021 |
Application | Utility: HYDROPHOBIC INTERACTION CHROMATOGRAPHY-COUPLED NATIVE MASS SPECTROMETRY FOR ANTIBODY ANALYSIS Filling date: 12 Sep 2025 Issue date: 8 Apr 2021 |
Application | Utility: GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHODS OF USE THEREOF Filling date: 12 Sep 2025 Issue date: 8 Apr 2021 |
Application | Utility: METHODS FOR REDUCING OR ELIMINATING THE NEED FOR LIPOPROTEIN APHERESIS IN PATIENTS WITH HYPERLIPIDEMIA BY ADMINISTERING ALIROCUMAB Filling date: 12 Sep 2025 Issue date: 8 Apr 2021 |
Grant | Utility: Compositions comprising IL6R antibodies for the treatment of uveitis and macular edema and methods of using same Filling date: 12 Sep 2025 Issue date: 6 Apr 2021 |
Grant | Utility: Cell culture medium for eukaryotic cells Filling date: 12 Sep 2025 Issue date: 30 Mar 2021 |
Grant | Utility: Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation Filling date: 12 Sep 2025 Issue date: 30 Mar 2021 |
Application | Utility: NON-HUMAN ANIMALS THAT MAKE SINGLE DOMAIN BINDING PROTEINS Filling date: 12 Sep 2025 Issue date: 25 Mar 2021 |
Application | Utility: USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS Filling date: 12 Sep 2025 Issue date: 25 Mar 2021 |
Application | Utility: SINGLE CELL RNA-SEQ DATA PROCESSING Filling date: 12 Sep 2025 Issue date: 25 Mar 2021 |
Application | Utility: ANTI-PTCRA ANTIBODY-DRUG CONJUGATES AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 25 Mar 2021 |
Application | Utility: METABOLICALLY OPTIMIZED CELL CULTURE Filling date: 12 Sep 2025 Issue date: 25 Mar 2021 |
Grant | Utility: Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments Filling date: 12 Sep 2025 Issue date: 23 Mar 2021 |
Grant | Utility: Method for generating a humanized transgenic mouse comprising a human APRIL gene Filling date: 12 Sep 2025 Issue date: 23 Mar 2021 |
Grant | Utility: Mice that make V.sub.L binding proteins Filling date: 12 Sep 2025 Issue date: 23 Mar 2021 |
Application | Utility: VEGF Antagonist Formulations Filling date: 12 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: Methods of Treating Inflammatory Conditions Filling date: 12 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: LC-MS METHODS FOR ANTIBODY ISOTYPING AND QUANTIFICATION Filling date: 12 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: RADIOLABELED MET BINDING PROTEINS FOR IMMUNO-PET IMAGING Filling date: 12 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: TRANSCRIPTION MODULATION IN ANIMALS USING CRISPR/CAS SYSTEMS DELIVERED BY LIPID NANOPARTICLES Filling date: 12 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: NON-HUMAN ANIMALS WITH MODIFIED IMMUNOGLOBULIN HEAVY CHAIN SEQUENCES Filling date: 12 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: ANTI-CD63 ANTIBODIES, CONJUGATES, AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 18 Mar 2021 |
Grant | Utility: Human antibodies to GFR.alpha.3 and methods of making thereof Filling date: 12 Sep 2025 Issue date: 16 Mar 2021 |
Grant | Utility: Fusion protein comprising apelin and an anti-APLNR antibody Filling date: 12 Sep 2025 Issue date: 16 Mar 2021 |
Application | Utility: RODENTS HAVING A HUMANIZED TMPRSS GENE Filling date: 12 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: HUMANIZED T CELL CO-RECEPTOR MICE Filling date: 12 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: Cell Culture Medium for Eukaryotic Cells Filling date: 12 Sep 2025 Issue date: 11 Mar 2021 |
Showing 200 to 250 of 704 patents.